TickerFacts.

Transcode Therapeutics, Inc. (RNAZ): Shares Outstanding

Annual figures by period end, from SEC filings.

Stock splits: 1-for-20, first reflected in a filing dated 2023-08-14; 1-for-42, first reflected in a filing dated 2024-08-14; 1-for-28, first reflected in a filing dated 2025-08-14. Figures are as filed: per-share figures and share counts last reported before a split are on the old share basis, so changes and growth rates across a split are not shown. Splits are read from the filings' own restatements, so a share conversion in a merger or reorganization shows up the same way.

917.0K
As of 2025-12-31
1.01M
As of 2026-06-30
12.90M2020-12-31: 4.64M2021-12-31: 12.90M2022-12-31: 16.2K2023-12-31: 19.0K2024-12-31: 36.8K2025-12-31: 917.0K917.0K
2020-12-31 Shares Outstanding (shares) 2025-12-31

Paler bars were last filed before a stock split, on the old share basis.

Period endedShares OutstandingChange YoYSource filing
2025-12-31917.0Kn/m2026-04-15, Balance as of period end
2024-12-3136.8Kn/c2026-04-15, Balance as of period end
2023-12-3119.0Kn/c2025-04-15, Balance as of period end
2022-12-3116.2Kn/c2024-04-01, Balance as of period end
2021-12-3112.90M+178.3%2023-03-31, Balance as of period end
2020-12-314.64Mn/a2022-03-31, Balance as of period end